ArticleCancer management and research2020

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer.

Hai-Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.